UCSF

Desai’s drug delivery research focus of agreement between UCSF and Zcube

Drug delivery research led by UCSF’s Tejal Desai, PhD, will now be supported by an exclusive worldwide license agreement between UCSF and Zcube s.r.l. The agreement focuses on drug delivery micro patches, developed by Desai, which stick to the lining of the intestine where they release their precise medication payloads directly into the intestinal lining and then into the bloodstream. The packets reduce the amount of medication required in each dose while increasing the amount of medication that reaches the bloodstream. Desai is a faculty member in the UCSF Department of Bioengineering and Therapeutic Sciences. Zcube s.r.l. is the research corporate venture arm of Italian pharmaceutical leader Zambon Co., S.p.A.

More

UCSF Collaborates with Zcube to Develop New Ways to Deliver Drugs


About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.